6th Microbiome Movement - Drug Development Summit Europe
Evvnt Promotion / evvnt
Archivo
25.01.2022 - 27.01.2022Online, United Kingdom
Time: 10:00 AM - 5:50 PM
Temas de la conferencia As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Cuota del Congreso Drug Developer - Conference Only (digital) GBP 1549.00,
Academic - Conference Only (digital) GBP 1299.00,
Solution & Service Provider - Conference Only (digital) GBP 1899.00
Cantacto organizador 83 Great Titchfield Street W1W 6RH London United Kingdom